Regional Brain Metabolism and Treatment Response in Panic Disorder Patients: An [<sup>18</sup>F]FDG-PET Study

Abstract

Abnormal neocortical function appears to be associated with the pathophysiology of PD and escitalopram exerts its therapeutic action by modulating brain activity at the level of the neocortex and limbic system, notably the amygdala and parahippocampal gyrus.